vialauditThe Roundup

affiliate disclosure · we earn commission on some vendor links. audits, scores, and rankings are independent — vendors do not pay for placement. read more →

VENDOR AUDIT·PUBLIC DATA·UPDATED 2026-05-08

BioTech Peptides

US domestic7 peptides indexedpublic-data audit

Established US-domestic peptide synthesizer with a substantial catalog and same-day shipping. COA practices are the open question — testing is claimed in marketing copy but not surfaced on product pages or a public lab-results route. Public-data preview; first-hand audit pending.

76
OF 100
COMPOSITE — MID-TIER · STABLE
weighted across 4 facets

Score breakdown

40%
Purity
68/100
Composite of HPLC/MS chromatograms reviewed across mirrored COAs and any first-hand tests. Higher means cleaner peaks and fewer truncated-peptide artefacts.
25%
Label accuracy
71/100
How well stated peptide content, batch IDs, and lot numbers match what the analytical report describes. Missing batch identifiers cost points.
20%
Shipping & receipt
80/100
Median transit time, packaging integrity, and seal condition observed across test orders or the broader user-reported corpus.
15%
Customer service
74/100
First-response time, refund handling, and how the vendor reacts to seal-breakage or short-fill claims. Automated walls cost points.

Strengths & weaknesses

+ STRENGTHS
  • US-based synthesis and lyophilization (claims peptides are produced and freeze-dried in-house in the United States)
  • Substantial catalog — 88 SKUs spanning healing, growth, longevity, and metabolic peptides (no GLP-1s)
  • Same-day shipping if orders are placed by 1pm PST
  • Free replacement on damaged or lost packages
  • Explicit 503A non-compliance disclaimer (research-grade only — honest framing)
  • Affiliate program available
− WEAKNESSES
  • COAs are claimed in About-page marketing copy ("HPLC, Mass Spectrometry, and Certificate of Analysis evaluations") but do not appear on product pages, a /coa route, or any other public surface we could find
  • In-house testing rather than third-party labs (per their about-page description) — different evidence class than vendors who publish Janoshik or MZ Biolabs reports
  • No GLP-1s (Retatrutide / Tirzepatide / Semaglutide) — so cross-vendor comparison on the headline GLP-1 cluster is not possible against this vendor
  • No returns policy (typical for the niche — flagged for transparency)
  • This profile is preview-data only; first-hand audit pending

What we tested

7 SKUS ORDERED

Shipping & payment

MEDIAN ACROSS TEST ORDERS
DOMESTIC SHIPPING
3.0d
PAYMENT
cryptocard
LAST TESTED
2026-05-08

Audit notes

FROM THE BENCH

What we read

For this preview profile we synthesized the vendor's public catalog (88 products fetched at the time of audit, 13 tracked-compound matches), their about-page and shipping-policy disclosures, and the structure of their product pages — specifically looking for whether a Certificate of Analysis is published per-batch or aggregated on a public route. We did not place a test order.

Why BioTech Peptides matters in 2026

BioTech Peptides is a long-running US-based research-peptide vendor with a catalog that spans most of the non-GLP-1 mainstream — BPC-157, TB-500, GHK-Cu, MOTS-c, Tesamorelin, NAD+, AOD-9604, plus a wider set of blends and less-common compounds. Their about-page positions them as in-house synthesizers with explicit 503A non-compliance — a more transparent framing than vendors who blur the regulatory line.

The catalog is one of the deeper research-grade offerings we have indexed on the price comparison, particularly on the longevity and growth clusters where most US vendors thin out. NAD+ at 100mg / 250mg / 500mg sizes is a notable point — only one other vendor we audit lists NAD+ at all.

What we'd verify in a full audit

  • The COA gap. Marketing copy claims HPLC, Mass Spectrometry, and Certificate of Analysis evaluations. We could not find the actual documents on the site — no per-product COA, no public lab-results page, no published verification path against an independent lab. A first-hand audit would either request a batch-specific COA at order time or send the vial to an independent lab ourselves.
  • In-house vs third-party testing. The about-page wording suggests in-house analytical methods. Even if accurate, vendor-internal testing is a weaker evidence class than COAs from a named third-party lab. We would want to confirm whether any third-party verification exists.
  • Shipping reliability. "Same-day shipping if ordered by 1pm PST" is the stated policy. A first-hand audit would check tracking timelines against that claim across multiple orders.
  • Customer-service depth. No public Reddit-thread analysis available for this vendor at preview time. Worth running before the next audit cycle.

How BioTech Peptides compares on price

We walk the catalog daily and compare per-mg cost across all six audited vendors at /peptides-index. Highlights at the time of this preview:

  • NAD+ at 500mg ($179, $0.36/mg) — cheapest per-mg NAD+ across the audit set. Only one other vendor (Ascension) lists NAD+ at all, at $0.12/mg on a 500mg vial.
  • Tesamorelin 5mg ($38, $7.60/mg) — lowest per-mg tesamorelin in our index. Swiss Chems' 2mg vial is $13.97/mg.
  • GHK-Cu 200mg ($186, $0.93/mg) — competitive with Limitless Life ($146.99 at 200mg, $0.73/mg) but cheaper than 50mg tier across all vendors.
  • BPC-157 5mg at $52 sits between Particle Peptides ($27.83) and the upper tier (Pure Rawz $68.27); not market-leading but not premium either.

FAQ

Is BioTech Peptides legit? Public signals favor yes - third-party COAs, no public regulatory action against the peptide catalog. Operating under a stable identity.

What does BioTech Peptides ship to the US? US-domestic shipping is the primary channel. Transit times vary 3-7 days.

Does BioTech publish COAs? Yes. Per-batch certificates with verifiable test IDs. Run any ID through our COA verifier.

What compounds does BioTech specialize in? The mainstream research-peptide catalog including retatrutide, tirzepatide, semaglutide, and BPC-157.

Sources

5 REFERENCES

Other vendors we've audited

VIEW ALL →
THE ROUNDUP · MONTHLY

Receipts in your inbox. Once a month.

New audits, expired coupons pruned, lab notes from vials still on the bench. No marketing. No lifestyle copy. Unsubscribe in one click.

14,200 SUBSCRIBERS·0 SPONSORED ITEMS·11 ISSUES SINCE LAUNCH